Extracellular ADP is a powerful osteolytic agent: Evidence for signaling through the P2Y1 receptor on bone cells

FASEB Journal

Volumn 15, Issue 7, 2001, Pages 1139-1148

  Hoebertz, Astrid ^a,b   Meghji, Sajeda ^a   Burnstock, Geoffrey ^a,b   Arnett, Timothy R ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ADP; ATP; Bone resorption; Osteoclast; P2 receptors; P2Y1

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM ION; NUCLEOTIDE DERIVATIVE; PROSTAGLANDIN E2; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE CELL; CALCIUM TRANSPORT; CALVARIA; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOSINE DIPHOSPHATE; ANIMALS; BONE AND BONES; BONE RESORPTION; CALCIUM; CELLS, CULTURED; CHONDROCYTES; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; OSTEOBLASTS; OSTEOCLASTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; THIONUCLEOTIDES;

ANIMALIA;

EID: 0035025090     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0395com     Document Type: Article

References (49)

1. Ralevic, V., and Burnstock, G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492
2. Dixon, S. J., and Sims, S. M. (2000) P2 purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development. Drug Dev. Res. 49, 187-200
3. Morrison, M. S., Turin, L., King, B. F., Burnstock, G., and Arrnett, T. R. (1998) ATP is a potent stimulator of the activation and formation of rodent osteoclasts. J. Physiol. (Lond.) 511, 495-500
4. Hoebertz, A., Townsend-Nicholson, A., Glass, R., Burnstock, G., and Arnett, T. R. (2000) Expression of P2 receptors in bone and cultured bone cells. Bone 27, 503-510
5. 2+]; in rat osteoblastic cells by interaction with two receptor subtypes. Am. J. Physiol. 263, C1040-C1048
6. Schoefl, C., Cuthbertson, K. S., Walsh, C. A., Mayne, C., Cobbold, P., von zur Muhlen, A., Hesch, R. D., and Gallagher, J. A. (1992) Evidence For P2-purinoceptors on human osteoblast-like cells. J. Bone Miner. Res. 7, 485-491
7. Yu, H., and Ferrier, J. (1993) ATP induces an intracellular calcium pulse in osteoclasts. Biochem. Bioohys. Res. Commun. 191, 357-363
8. 2+ signaling in osteoclasts. Cell Signal, 6, 905-914
9. + channels in rat osteoclasts. J. Physiol. (Lond.) 503, 303-315
10. Yu, H., and Ferrier, J. (1995) Osteoclast ATP receptor activation leads to a transient decrease in intracellular pH. J. Cell. Sci. 108, 3051-3058
11. Arnett, T. R., and Spowage, M. (1996) Modulation of resorptive activity of rat osteoclasts by small changes in extracellular pH near the physiological range. Bone 18, 277-279
12. Murrills, R. J., Dempster, D. W., and Arnett, T. R. (1998) Isolation and culture of osteoclasts and osteoclast resorption assays. In Methods in Bone Biology (Arnett, T. R., and Henderson, B., eds.), pp. 64-105, Chapman and Hall, London
13. Meghji, S., Hill, P. A., and Harris, M. (1998) Bone organ cultures. In Methods in Bone Biology (Arnett, T. R., and Henderson, B., eds.), pp. 106-126, Chapman and Hall, London
14. Morrison, M. S., and Arnett, T. R. (1998) pH effects on osteoclast formation and activation. Bone 22 (Abstr.), 30S
15. 1 in osteoclast differentiation and survival. J. Cell. Sci. 113, 2445-2453
16. 1 purinergic receptor in neurons and glial cells of the central nervous system. Brain Res. 78, 50-58
17. - demic, Boston
18. 6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate. Br. J. Pharmacol. 124, 1-3
19. Jacobson, K. A., Hoffmann, C., Kim, Y. C., Camaioni, E., Nandanan, E., Jang, S. Y., Guo, D. P., Ji, X. D., von Kugelgen, L., Moro, S., Ziganshin, A. U., Rychkov, A., King, B. F., Brown, S. G., Wildman, S. S., Burnstock, G., Boyer, J. L., Mohanram, A., and Harden, T. K. (1999) Molecular recognition in P2 receptors: ligand development aided by molecular modeling and mutagenesis. Prog. Brain Res. 120, 119-132
20. Evans, R. J., Lewis, C., Buell, G., Valera, S., North, R. A., and Surprenant, A. (1995) Pharmacological characterization of heterologonsly expressed ATP-gated cation channels (P2X purinoceptors). Mol. Pharmacol. 48, 178-183
21. Bianchi, B. R., Lynch, K. J., Tourna, E., Niforatos, W., Burgard, E. C., Alexander, K. M., Park, H. S., Yu, H., Metzger, R., Kowaluk, E., Jarvis, M. F., and van Biesen, T. (1999) Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur. J. Pharmacol. 376, 127-138
22. Naemsch, L,. N., Weidema, A. F., Sims, S. M., Underhill, T. M., and Dixon, S. J. (1999) P2X4 purinoceptors mediate an ATP-activated, non-selective cation current in rabbit osteoclasts. J. Cell Sci. 112, 4425-4435
23. Kumagai, H., Sacktor, B., and Filburn, C. R. (1991) Purinergic regulation of cytosolic calcium and phosphoinositide metabolism in rat osteoblast-like osteosarcoma cells. J. Bone Miner. Res. 6, 697-708
24. Sistare, F. D., Rosenzweig, B. A., Contrera, J. G., and Jordan, B. (1994) Separate P2T and P2U purinergic receptors with similar second messenger signaling pathways in UMR-106 osteoblasts. J. Pharmacol. Exp. Ther. 269, 1049-1061
25. Dixon, C. J., Bowler, W. B., Walsh, C. A., and Gallagher, J. A. (1997) Effects of extracellular nucleotides on single cells and populations of human osteoblasts: contribution of cell heterogeneity to relative potencies. Br. J. Pharmacol. 120, 777-780
26. Bowler, W. B., Dixon, C. J., Halleux, C., Maier, R., Bilbe, G., Fraser, W. D., Gallagher, J. A., and Hipskind, R. A. (1999) Signaling in human osteoblasts by extracellular nucleotides. J. Biol. Chem. 274, 14315-14324
27. + stimulation of cell-mediated bone resorption in tissue culture. Am. J. Physiol. 253, E90-E98
28. 2 and cyclic adenosine 3′,5′-monophosphoric acid and their relationship to bone resorption in neonatal mouse calvaria cultures. Bone Miner. 11, 295-304
29. Needleman, P., Minkes, M. S., and Douglas, J. R., Jr. (1974) Stimulation of prostaglandin biosynthesis by adeninc nucleotides. Profile of prostaglandin release by perfused organs. Circ. Res. 34, 455-460
30. 2 purinoceptor to ATP revealed by changing extracellular pH. Br. J. Pharmacol. 117, 1371-1373
31. 2 receptor by neurotransmitters and related substances. Br. J. Pharmacol. 120, 221-224
32. Meghji, S., Morrison, M. S., Henderson, B., and Arnett, T. R. (2001) pH-dependence of bone resorption: mouse calvarial osteoclasts are activated by acidosis. Am. J. Physiol. 280, E112-119
33. Zanellato, N., Hoebertz, A., and Arnett, T. R. (2000) Low pH is a key requirement for osteoclast activation by RANKL. J. Bone Miner. Res. 15 (Abstr.), S387
34. Arnett, T. R., and Dempster, D. W. (1986) Effect of pH on bone resorption by rat osteoclasts in vitro. Endocrinology 119, 119-124
35. Webb, T. E., Simon, J., Krishek, B. J., Bateson, A. N., Smart, T. G., King, B. F., Burnstock, G., and Barnard, E. A. (1993) Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324, 219-225
36. Hechler, B., Vigne, P., Leon, C., Breittmayer, J. P., Gachet, C., and Frelin, C. (1998) ATP derivatives are antagonists of the P2Y, receptor: similarities to the platelet ADP receptor. Mol. Pharmacol. 53, 727-733
37. Vigne, P., Breittmayer, J. P., and Frelin, C. (1998) Analysis of the influence of nucleotidases on the apparent activity of exogenous ATP and ADP at P2Y, receptors. Br. J. Pharmocol. 125, 675-680
38. 2+ channel in neurones, with both adenosine triphosphates and diphosphates as potent agonists. Br. J. Pharmacol 129, 1063-1066
39. 1 receptor. Br. J. Pharmacol. 130, 664-668
40. Coade, S. B., and Pearson, J. D. (1989) Metabolism of adenine nucleotides in human blood. Circ. Res. 65, 531-537
41. Ogilvie, A. L. J., Berchtold, S., Lutz, M. B., Steinkasserer, A., and Schuler, G. (2000) ATP receptors and ectonucleotidases on bone-marrow dendritic cells (DC): novel pathways for maturation and differentiation? J. Invest. Dermatol. 114 (Abstr.), 226
42. Gordon, J. L. (1986) Extracellular ATP: effects, sources and fate. Biochem. J. 233, 309-319
43. Bowler, W. B., Tattersall, J. A., Hussein, R., Dixon, C. J., Cobbold, P. H., and Gallagher, J. A. (1998) Release of ATP by osteoblasts: modulation by fluid shear forces. Bone 22 (Abstr.), 3S
44. Peel, N. F., Eastell, R., and Russell, R. G. (1991) Osteoporosis in rheumatoid arthritis - the laboratory perspective. Br. J. Rheumatol. 30, 84-85
45. Bodin, P., and Burnstock, G. (1998) Increased release of ATP from endothelial cells during acute inflammation. Inflamm. Res. 47, 351-354
46. Peerschke, E. I., and Ghebrehiwet, B. (1998) Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis. Immunobiology 199, 239-249
47. Burnstock, G. (1997) The past, present and future of purine nucleotides as signaling molecules. Neuropharmacology 36, 1127-1139
48. Leong, W. S., Russell, R. G., and Caswell, A. M. (1994) Stimulation of cartilage resorption by extracellular ATP acting at P2-purinoceptors. Biochim. Biophys. Acta 1201, 298-304
49. Brown, C. J., Caswell, A. M., Rahman, S., Russell, R. G., and Buttle, D. J. (1997) Proteoglycan breakdown from bovine nasal cartilage is increased, and from articular cartilage is decreased, by extracellular ATP. Biochim. Biophys. Acta 1362, 208-220